Solid Biosciences Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.64 | -$0.64 | -$0.64 |
| Q2 2024 | 2 | -$0.66 | -$0.66 | -$0.66 |
| Q3 2024 | 7 | -$0.70 | -$0.63 | -$0.67 |
| Q4 2024 | 2 | -$0.69 | -$0.69 | -$0.69 |
| Q1 2025 | 3 | -$0.67 | -$0.67 | -$0.67 |
| Q2 2025 | 3 | -$0.68 | -$0.68 | -$0.68 |
| Q3 2025 | 6 | -$0.70 | -$0.70 | -$0.70 |
| Q4 2025 | 5 | -$0.73 | -$0.73 | -$0.73 |
| Q1 2026 | 4 | -$0.64 | -$0.64 | -$0.64 |
| Q2 2026 | 3 | -$0.63 | -$0.63 | -$0.63 |
| Q3 2026 | 2 | -$0.66 | -$0.66 | -$0.66 |
| Q4 2026 | 2 | -$0.69 | -$0.69 | -$0.69 |
Solid Biosciences Inc. Earnings Date And Information
Solid Biosciences Inc. last posted its earnings results on Tuesday, August 13th, 2024. The company reported $-0.61 earnings per share for the quarter, topping analysts' consensus estimates of $-0.68 by $0.07. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Solid Biosciences Inc. has generated $-5 earnings per share over the last year ($-4.83 diluted earnings per share) and currently has a price-to-earnings ratio of -2.68. Solid Biosciences Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based on prior year's report dates.
Solid Biosciences Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/13/2024 | Q2 2024 | -$0.68 | -$0.61 | 0.07 | $404,700 | $0 |
| 05/15/2024 | Q1 2024 | -$0.57 | -$0.64 | -0.07 | $0 | |
| 03/13/2024 | Q4 2023 | -$1.01 | -$1.00 | 0.01 | $4.74 M | |
| 11/08/2023 | Q3 2023 | -$1.20 | -$1.05 | 0.15 | $1.47 M | $0 |
| 08/14/2023 | Q2 2023 | -$1.52 | -$1.25 | 0.27 | $2.20 M | $0 |
| 05/11/2023 | Q1 2023 | -$1.83 | -$1.44 | 0.39 | $0 | |
| 03/23/2023 | Q4 2022 | -$2.70 | $0.24 | 2.94 | $8.09 M | |
| 11/10/2022 | Q3 2022 | -$2.59 | -$2.61 | -0.02 | $300,000 | $0 |
| 08/11/2022 | Q2 2022 | -$3.15 | -$3.30 | -0.15 | $4.08 M | $6.17 M |
| 04/27/2022 | Q1 2022 | -$2.70 | -$3.37 | -0.67 | $1.93 M | |
| 03/14/2022 | Q4 2021 | -$3.00 | -$2.53 | 0.47 | $3.15 M | |
| 11/03/2021 | Q3 2021 | -$2.85 | -$2.40 | 0.45 | $2.13 M | $3.54 M |
| 08/16/2021 | Q2 2021 | -$2.70 | -$2.55 | 0.15 | $2.82 M | $3.59 M |
| 05/14/2021 | Q1 2021 | -$4.20 | -$2.84 | 1.36 | $3.34 M | |
| 03/15/2021 | Q4 2020 | -$5.10 | -$6.64 | -1.54 | $98.32 M | |
| 11/05/2020 | Q3 2020 | -$4.80 | -$6.60 | -1.8 | $0 | |
| 08/06/2020 | Q2 2020 | -$6.00 | -$5.91 | 0.09 | $0 | |
| 05/07/2020 | Q1 2020 | -$9.00 | -$8.33 | 0.67 | $0 | |
| 03/13/2020 | Q4 2019 | -$9.96 | $0 | |||
| 11/12/2019 | Q3 2019 | -$9.45 | -$10.10 | -0.65 | $0 |
Solid Biosciences Inc. Earnings: Frequently Asked Questions
-
When is Solid Biosciences Inc.'s earnings date?
Solid Biosciences Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based off last year's report dates.
-
Did Solid Biosciences Inc. beat their earnings estimates last quarter?
In the previous quarter, Solid Biosciences Inc. (:SLDB) reported $-0.61 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.68 by $0.07.
-
How can I listen to Solid Biosciences Inc.'s earnings conference call?
The conference call for Solid Biosciences Inc.'s latest earnings report can be listened to online.
-
How can I read Solid Biosciences Inc.'s conference call transcript?
The conference call transcript for Solid Biosciences Inc.'s latest earnings report can be read online.
-
How much profit does Solid Biosciences Inc. generate each year?
Solid Biosciences Inc. (:SLDB) has a recorded net income of $0. Solid Biosciences Inc. has generated $-4.83 earnings per share over the last four quarters.
-
What is Solid Biosciences Inc.'s price-to-earnings ratio?
Solid Biosciences Inc. (:SLDB) has a price-to-earnings ratio of -2.68 and price/earnings-to-growth ratio is -0.17.
